PMID: 9554074Apr 29, 1998Paper

Cryptosporidiosis: laboratory investigations and chemotherapy

Advances in Parasitology
S Tzipori

Abstract

Much progress has been achieved in the last decade in terms of development of laboratory techniques, reagents and in vivo models. They have undoubtedly contributed to better and more accurate investigations. Despite a concerted effort by many investigators, however, breakthroughs have been minimal. The development of adequate in vitro and in vivo techniques for drug screening, and the intensified and systematic screening, has so far not resulted in the discovery of an effective therapy. The reason for the failure may well be due to the unique biological niche the parasite occupies (discussed at length in the first chapter in this volume). Its location beneath the cell membrane, but outside the cell cytoplasm, may prove a crucial element that needs to be considered when designing new therapeutic approaches. Laboratory investigations on two drugs currently used against chronic Cryptosporidium parvum in acquired immune deficiency syndrome (AIDS) are discussed. This chapter also provides information and the rationale for work in progress in our laboratory that relates to the development of novel approaches for control of the disease. This includes the identification of molecular targets of parasite origin for drug design, and studi...Continue Reading

Citations

Oct 25, 2013·Parasitology Research·Zahra OmidianParviz Shayan
Jun 29, 2001·International Journal for Parasitology·N S HijjawiR C Thompson
Apr 3, 2003·International Journal for Parasitology·Liyan ChenJacqueline Sharon
Jan 5, 2002·Molecular and Biochemical Parasitology·Xiaochuan FengGiovanni Widmer
Mar 1, 2002·Journal of Microbiological Methods·Walter Quintero-BetancourtJoan B Rose
Jan 18, 2003·Veterinary Parasitology·Z EgyedI Varga
Sep 28, 1999·FEMS Microbiology Letters·A ArmsonR C Thompson
Aug 23, 2002·Microbes and Infection·Saul Tzipori, Honorine Ward
Feb 1, 1990·Epidemiology and Infection·D P Casemore
Apr 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Siobhan M MorJeffrey K Griffiths
Jul 26, 2008·The Journal of Antimicrobial Chemotherapy·Pavel KleinGiorgio Scalise
Aug 1, 1990·Antimicrobial Agents and Chemotherapy·V McDonaldK P McAdam
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·M J ArrowoodM C Healey
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·G J Leitch, Q He
Apr 7, 2006·Applied and Environmental Microbiology·Sultan TanriverdiGiovanni Widmer
Jan 10, 2002·Clinical Microbiology Reviews·Paul R Hunter, Gordon Nichols
Sep 7, 2006·Journal of Clinical Microbiology·O SunnotelC J Lowery
May 30, 2006·The Journal of Parasitology·Donald GirouardSaul Tzipori
Apr 14, 2007·International Journal of Environmental Research and Public Health·Christine L BeanGiovanni Widmer
May 9, 2003·Folia Parasitologica·Xunde LiJean-François Rossignol
Dec 1, 1999·International Journal for Parasitology·R B Gasser, P O'Donoghue
Sep 6, 2011·International Journal for Parasitology·P Karanis, H M Aldeyarbi
Oct 6, 2001·Gastroenterology Clinics of North America·D E Katz, D N Taylor
Nov 20, 2010·Microbes and Infection·Gregorio Perez-CordonHanping Feng
Aug 1, 2009·Journal of Biomedicine & Biotechnology·César OrdóñezDavid Ordóñez
Apr 4, 2013·Gut Microbes·Quanshun ZhangSaul Tzipori
Jul 28, 2009·Molecular and Biochemical Parasitology·Yi-Lin YangGiovanni Widmer
Oct 16, 2004·Expert Review of Anti-infective Therapy·Anthony ArmsonJames A Reynoldson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.